No credit card. No commitment.
5000+ G2 reviews
Model Medicines
Research
Founded in 2019
San Diego, CaliforniaModel Medicines
ResearchFounded in 2019San Diego, California
EmployeesModel Medicines' financial review
Employees
17
Total Funding
5.1M
Last Funding Round
950K
Model Medicines information
Model Medicines is an AI-driven, human health company using AI to model all of chemistry and human biology, to accelerate the creation of life-changing drugs. The company was founded in 2019 to deliver on the promise of AI-Drug discovery. With more than 182 compounds for 26 targets, they are delivering on the promise of AI-drug discovery. The company has developed a robust pipeline of patent-pendi...
Model Medicines is an AI-driven, human health company using AI to model all of chemistry and human biology, to accelerate the creation of life-changing drugs. The company was founded in 2019 to deliver on the promise of AI-Drug discovery. With more than 182 compounds for 26 targets, they are delivering on the promise of AI-drug discovery. The company has developed a robust pipeline of patent-pending therapeutics for oncology, infectious diseases, gastric disorders, neurological disorders, and weight disorders. The company is based in La Jolla, CA.
Model Medicines industries
Artificial intelligence & drug discovery
Research
Biotechnology research
Model Medicines' financial review
Employees
17
Total Funding
5.1M
Last Funding Round
950K
Employee Metrics
Technologies
Email Providers
Other
Marketing Automation
Widgets
Other
E-commerce Platforms
Notable Alumni
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
